rheumatology
Medicines

Updated: Australian patients part of a “world first” experiment

Australian rheumatology patients will be the subjects of a worrying “world first” experiment if pharmacists are permitted to substitute biologics for biosimilars, the ARA warns. President Mona Marabani appeared at a Senate Economics Committee hearing on Thursday to voice concerns about the government’s move to save $800 million by allowing pharmacists to substitute biosimilars for ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic